2012, ISBN: 9782817803364
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and … Plus…
Orellfuessli.ch Nr. 34928972. Frais d'envoi, Sofort per Download lieferbar, zzgl. Versandkosten, Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage. (EUR 16.66) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), Auflage, [PU: Springer-Verlag], [ED: 1], Springer-Verlag, 2012
lehmanns.de Frais d'envoiDownload sofort lieferbar. (EUR 29.95) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, [ED: 1], Auflage, eBook Download (PDF), eBooks, [PU: Springer-Verlag]
lehmanns.de Frais d'envoiDownload sofort lieferbar, , Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), 2012, [PU: Springer Paris], Springer Paris, 2012
lehmanns.de Frais d'envoiDownload sofort lieferbar. (EUR 0.00) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, 2012, eBook Download (PDF), eBooks, [PU: Springer Paris]
lehmanns.de Frais d'envoiDownload sofort lieferbar, , Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
2012, ISBN: 9782817803364
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and … Plus…
Jean-Louis Prugnaud; Jean-Louis Prugnaud; Jean-Hugues Trouvin; Jean Hugues Trouvin:
Biosimilars - Première édition2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), Auflage, [PU: Springer-Verlag], [ED: 1], Springer-Verlag, 2012
2012
ISBN: 9782817803364
A New Generation of Biologics, [ED: 1], Auflage, eBook Download (PDF), eBooks, [PU: Springer-Verlag]
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), 2012, [PU: Springer Paris], Springer Paris, 2012
2012, ISBN: 9782817803364
A New Generation of Biologics, 2012, eBook Download (PDF), eBooks, [PU: Springer Paris]
Données bibliographiques du meilleur livre correspondant
Auteur: | |
Titre: | |
ISBN: |
Informations détaillées sur le livre - Biosimilars
EAN (ISBN-13): 9782817803364
ISBN (ISBN-10): 2817803361
Date de parution: 2012
Editeur: Springer-Verlag
87 Pages
Langue: eng/Englisch
Livre dans la base de données depuis 2012-09-27T17:56:33+02:00 (Zurich)
Page de détail modifiée en dernier sur 2023-03-01T02:27:40+01:00 (Zurich)
ISBN/EAN: 9782817803364
ISBN - Autres types d'écriture:
2-8178-0336-1, 978-2-8178-0336-4
Autres types d'écriture et termes associés:
Auteur du livre: hugues, jean louis lou
Données de l'éditeur
Auteur: Jean-Louis Prugnaud; Jean-Hugues Trouvin
Titre: Biosimilars - A New Generation of Biologics
Editeur: Springer; Springer Paris
90 Pages
Date de parution: 2012-11-27
Paris; FR
Imprimé / Fabriqué en
Langue: Anglais
117,69 € (DE)
142,00 CHF (CH)
Available
XVIII, 90 p.
EA; E107; eBook; Nonbooks, PBS / Medizin/Klinische Fächer; Onkologie; Verstehen; Biomedicine; Biosimilars; Cost; Immunogenicity; Interchangeability; C; Oncology; Nephrology; Pharmacy; Pharmaceutical Sciences/Technology; Immunology; Oncology; Nephrology; Pharmacy; Pharmaceutics; Immunology; Medicine; Nierenheilkunde, Nephrologie; Pharmazie, Apotheke; Medizinische Chemie, Pharmazeutische Chemie; Immunologie; BB
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context.Autres livres qui pourraient ressembler au livre recherché:
Dernier livre similaire:
9782817805146 Biosimilars (Jean-Louis Prugnaud; Jean-Hugues Trouvin)
< pour archiver...